Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-25-063065

EVP, Chief Development Officer acquired 11,694 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Forbes William P EVP, Chief Development Officer 2025-04-30 Option exercise +11,694 122,566 D
Derivatives
Forbes William P EVP, Chief Development Officer 2025-04-30 Option exercise · Restricted Stock Units −11,694 175,416 D
Loading xslF345X05/ownership.xml…